Acesso Livre 1

TÉTANO

(1)

HEIJSTEK, M. W. et al. Differences in persistence of measles, mumps, rubella, diphtheria and tetanus antibodies between children with rheumatic disease and healthy controls: a retrospective cross-sectional study. Annals of the rheumatic diseases, London, v. 71, n. 6, p. 948-954, June 2012.

Leia o artigo

Acesso Livre 2

(2)

HIROBE, S. et al. Clinical study of transcutaneous vaccination using a hydrogel patch for tetanus and diphtheria, Vaccine, Kidlington, v. 30, n. 10, p. 1847-1854, Feb. 2012.

Leia o artigo

(3)

HOPE, V. D. et al. A decade of spore-forming bacterial infections among European injecting drug users: pronounced regional variation. American journal of public health, Washington, v. 102, n. 1, p. 122-125, Jan. 2012.

Leia o artigo

(4)

LOAN, H. T. et al. Semi-recumbent body position fails to prevent healthcare-associated pneumonia in Vietnamese patients with severe tetanus. Transactions of the Royal Society of Tropical Medicine and Hygiene, London, v. 106, n. 2, p. 90-97, Feb. 2012.

Leia o artigo

(5)

MANGILLI, L. D. et al. Rehabilitative management of swallowing and oral-motor movements in patients with tetanus of a public service in Brazil. Acta tropica, Basel, v. 122, n. 3, p. 241-246, June 2012.

Leia o artigo

(6)

MORI, M. et al. Postoperative tetanus after laparoscopic obturator hernia repair for strangulated ileus: report of a case. Surgery today, Tokyo, v. 42, n. 5, p. 470-474, May 2012.

Leia o artigo

(7)

SELMAN, M. H. et al. Changes in antigen-specific IgG1 Fc N-glycosylation upon influenza and tetanus vaccination. Molecular & cellular proteomics, Bethesda, v. 11, n. 4, p. M111.014563, Apr. 2012.

Leia o artigo

(8)

TIERNEY, R. et al. A single-dose cytomegalovirus-based vaccine encoding tetanus toxin fragment C induces sustained levels of protective tetanus toxin antibodies in mice. Vaccine, Kidlington, v. 30, n. 20, p. 3047-3052, Apr. 2012.

Leia o artigo

(9)

VAN DER MEEREN, O. et al. Immunogenicity of InfanrixTM hexa administered at 3, 5 and 1 months of age. Vaccine, Kidlington, v. 30, n. 17, p. 2710-2714, Apr. 2012.

Leia o artigo

(10)

WESTON, W. M. et al. Vaccination of adults 65 years of age and older with tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Boostrix®): results of two randomized trials. Vaccine, Kidlington, v. 30, n. 9, p. 1721-1728, Feb. 2012.

Leia o artigo